{
  "actions": [
    {
      "acted_at": "2012-05-24",
      "action_code": "",
      "how": "roll",
      "references": [],
      "result": "fail",
      "roll": 105,
      "text": "Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.",
      "type": "vote",
      "vote_type": "vote",
      "where": "s"
    },
    {
      "acted_at": "2012-05-24",
      "action_code": "",
      "references": [],
      "text": "Amendment SA 2111 proposed by Senator Bingaman. (consideration: CR S3542-3543, S3547-3548, S3553-3554) To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive \"pay-for-delay\" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.",
      "type": "action"
    },
    {
      "acted_at": "2012-05-24",
      "action_code": "93000",
      "references": [
        {
          "reference": "CR S3542-3543, S3547-3548, S3553-3554",
          "type": "consideration"
        }
      ],
      "text": "Senate amendment proposed (on the floor): Amendment SA 2111 proposed by Senator Bingaman.",
      "type": "action"
    },
    {
      "acted_at": "2012-05-24",
      "action_code": "97000",
      "references": [],
      "text": "Roll call votes on amendments in Senate: Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.",
      "type": "action"
    },
    {
      "acted_at": "2012-05-24",
      "action_code": "95000",
      "references": [],
      "text": "Senate amendment not agreed to: Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.",
      "type": "action"
    },
    {
      "acted_at": "2012-05-17",
      "action_code": "91000",
      "references": [],
      "text": "Senate amendment submitted",
      "type": "action"
    }
  ],
  "amendment_id": "samdt2111-112",
  "amendment_type": "samdt",
  "amends_amendment": null,
  "amends_bill": {
    "bill_id": "s3187-112",
    "bill_type": "s",
    "congress": 112,
    "number": 3187
  },
  "amends_treaty": null,
  "chamber": "s",
  "congress": "112",
  "introduced_at": "2012-05-17",
  "number": 2111,
  "proposed_at": "2012-05-24T04:00:00Z",
  "purpose": "To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive \"pay-for-delay\" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.",
  "sponsor": {
    "bioguide_id": "B000468",
    "district": null,
    "name": "Bingaman, Jeff",
    "state": "NM",
    "title": "Sen.",
    "type": "person"
  },
  "status": "fail",
  "status_at": "2012-05-24",
  "updated_at": "2022-02-25T17:31:35Z"
}